RayzeBio Inc(NASDAQ:RYZB) 
RayzeBio is a clinical-stage radiopharmaceutical therapeutics (“RPT”) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs.
Website: https://rayzebio.com/
Founded: 2020
CEO: Dr. Kenneth Song
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-09-14
P
O 18.00
H 18.00
L 18.00
C 18.00
V 0
10EMA 18.00
20EMA 18.00
60EMA 18.00
120EMA 18.00
250EMA 18.00